Fox Run Management L.L.C. Purchases 1,432 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fox Run Management L.L.C. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 294.7% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,918 shares of the medical equipment provider’s stock after buying an additional 1,432 shares during the period. Fox Run Management L.L.C.’s holdings in Intuitive Surgical were worth $1,001,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at about $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $492.49 on Friday. The firm’s fifty day moving average is $562.24 and its two-hundred day moving average is $531.67. The firm has a market cap of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.